RPA has been commissioned by the European Chemicals Agency (ECHA) to undertake a study to obtain detailed market segmentation information on potential SME users of the ECHA Cloud Services, concentrating on, but not limited to, REACH registration.

ECHA commissioned a study to better understand the impact of the REACH & CLP implementation on change drivers at strategic level for these organisations within their sustainability framework.

The subject of the service is the quantification and valuation of the human health impacts of chemicals, based on quality-adjusted life-years (QALYs) and disability-adjusted life-years (DALYs) (and related concepts). The human health impacts of interest are those relevant to the chemicals which have been subject to previous REACH Annex XVII restrictions/restriction dossiers, which are listed in REACH Annex XIV or are on the 'Candidate List', or which are expected to be subject to restriction or prioritisation in the near future. Many of these chemicals are likely to be associated with health impacts which have already been subject to measurement using QALYs and DALYs.

RPA supported ECHA in preparing an Annex XV dossier on the use of cadmium in plastics (Lot 1) and paints (Lot 2).

RPA led a multi-national team including TNO, RIVM, DHI, Okopol and Milieu which provides technical support to the European Chemicals Agency (ECHA).

Risk and Policy Analysts Ltd has been tasked to provide ECHA with the necessary information for the quantitative assessment of DecaBDE emissions from its uses, a market overview and sufficient information about the availability, technical feasibility and the risks of alternatives for the preparation of the Annex XV restriction dossier.